Red blood cell metabolism

Red blood cell metabolism refers collectively to the network of biochemical pathways that sustain erythrocyte function. The primary foundations are glycolysis, which provides ATP; the pentose phosphate pathway, which generates NADPH for antioxidant defense; and various redox reactions critical for maintaining membrane integrity and hemoglobin function. Additional components include purine/nucleoside turnover and specialized shunts like the Luebering-Rapaport pathway producing modulators such as 2,3-BPG. Unlike most cells, mature human erythrocytes lack mitochondria; thus all ATP is generated anaerobically via cytoplasmic enzymes. Fine-tuning these interconnected processes enables efficient oxygen loading/unloading by hemoglobin while protecting against oxidative damage during circulation. Disruption in any aspect can contribute to diseases such as anemia or sickle cell disease. While individual enzymes within these pathways are potential therapeutic targets (e.g., pyruvate kinase), "red blood cell metabolism" itself is not considered a singular druggable entity but rather an integrated physiological system essential for life.

Other names

Erythrocyte metabolismRBC metabolism

Drugs may: - Modulate glycolytic flux or pentose phosphate pathway activity - Alter redox balance by affecting NADH/NADPH levels or glutathione recycling - Bind directly to hemoglobin or membrane proteins affecting metabolic enzyme complexes